Six‐months immunogenicity of BNT162b2 mRNA vaccine in heart transplanted and ventricle assist device‐supported patients

AIMS: To assess the 6 months immunogenicity to severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) mRNA vaccine in a population of heart transplanted (HTx) recipients and left ventricular assist device (LVAD)‐supported patients. METHODS AND RESULTS: A prospective single‐centre cohort study...

Descripción completa

Detalles Bibliográficos
Autores principales: Itzhaki Ben Zadok, Osnat, Shaul, Aviv A., Ben‐Avraham, Binyamin, Yaari, Vicky, Ben Zvi, Haim, Eliakim‐Raz, Noa, Yahav, Dafna, Abed, Galia, Abuhazira, Miriam, Barac, Yaron D., Mats, Israel, Shochat, Tzippy, Aravot, Dan, Kornowski, Ran, Ben‐Gal, Tuvia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934960/
https://www.ncbi.nlm.nih.gov/pubmed/34981657
http://dx.doi.org/10.1002/ehf2.13798

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934960/
https://www.ncbi.nlm.nih.gov/pubmed/34981657
http://dx.doi.org/10.1002/ehf2.13798

Ejemplares similares